1. Will other drugmakers end up with deals like Endo’s $10M opioid settlement? — AstraZeneca Imfinzi combo fails advanced lung cancer study — FDA says they were “lucky” with Novartis data manipulation controversy — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. What happened a year ago this week in biopharma? Regeneron’s Eylea approval, Novartis’ new ethics czar, Vertex’s Kalydeco, and Opidvo’s SCLC approval click to review and read a current update of the big stories from one year ago
    Dismiss Notice

Caswood

Anonymous board for Caswood

Sort By:
Title
Replies Views
Last Message
  1. anonymous
    Replies:
    0
    Views:
    1,772
  2. Anonymous
    Replies:
    18
    Views:
    10,177
  3. Anonymous
    Replies:
    2
    Views:
    5,428
  4. Anonymous
    Replies:
    0
    Views:
    2,491
  5. Anonymous
    Replies:
    3
    Views:
    4,529
  6. Anonymous
    Replies:
    3
    Views:
    6,331
  7. Anonymous
    Replies:
    0
    Views:
    3,242
  8. Anonymous
    Replies:
    4
    Views:
    3,510
  9. Anonymous
    Replies:
    1
    Views:
    3,559
  10. Anonymous
    Replies:
    23
    Views:
    11,199
  11. Anonymous
    Replies:
    13
    Views:
    7,673

Thread Display Options

Loading...